The IUIS Congress, a triennial gathering of the global immunology community, drew approximately 6,000 attendees from 120 countries. At the event, Professor Jae Seung Kang of Seoul National University College of Medicine delivered a highly anticipated presentation titled “Effects of Aptamin C on NK Cell Activation and Cytotoxicity,” which attracted considerable interest from the scientific community.
Professor Kang presented research showing that Aptamin C overcomes the inherent instability of conventional vitamin C in the body and enhances natural killer (NK) cell activity and cytotoxicity. “Aptamin C shows remarkable promise in boosting NK cell function and antioxidant capabilities,” Kang stated, underscoring its potential as a breakthrough in immunotherapy.
Aptamin C combines DNA aptamer technology to inhibit vitamin C oxidation, improving its stability and antioxidant effects. The compound has drawn attention from experts in immuno-oncology and cell therapy as a potential candidate for next-generation antioxidant and immune-modulating treatments.
The announcement reflects Nexmoss’s efforts to strengthen its global presence and expand into overseas markets.
Kim Kuk Ju, HEALTH IN NEWS TEAM
press@hinews.co.kr
